Abstract:atresia.However, utility of HIDA scan in preterm neonates is not well-established.Herein, we aim to (1) review the etiologies of neonatal cholestasis among term and preterm neonates with cholestasis, (2) identify clinical variables associated with a diagnosis of BA and non-BA and (3) investigate the utility of HIDA in predicting BA among preterm neonates.Methods: Retrospective cohort study of neonates born and investigated for neonatal cholestasis at 2 co-located neonatal and children facilities from January 2013 to December 2017.Demographic, clinical, laboratory variables and ultrasound features were collected to identify for variables associated with diagnosis of BA and non-BA via univariable and multivariable analysis.Sensitivity of specificity of HIDA in predicting BA were calculated for term and preterm neonates.Results: 139 neonates with cholestasis were identified (40 term; 99 preterm), of which 28 term and 24 preterm underwent HIDA investigation.Among the term neonates, the etiologies of cholestasis were BA (18%), intestinal failure related liver disease (IFALD) (13%), cytomegalovirus (1%), idiopathic neonatal hepatitis (1%).Among the preterm neonates, these proportions were IFALD (66%), CMV/sepsis related (5%), BA (2%), cystic fibrosis (2%).Incidence of BA among neonatal cholestasis was higher in term(1:6) than preterm(1:50) cohorts.(OR 10.29; 95% CI 2.06-49.97,P=0.0024) Variables significantly associated with BA on univariable regression analysis were: higher birth weight(OR P=0.002), presence of acholic stool(P=0.002),absent gallbladder(P=0.003)or abnormal gallbladder morphology(P=0.024).Variables significantly associated with non-BA on multivariable regression analysis were gestational age ≤32 weeks(P=0.046),total parenteral nutrition ≥14 days(P=0.009).In predicting BA, non-draining HIDA demonstrated a lower specificity (73% vs 90%) and lower PPV (25% vs 78%) in preterm compared to term neonates.Conclusions: Etiologies of cholestasis among preterm neonates differ from those in term neonates and neonatal cholestasis in preterm may not warrant extensive evaluations for exclusion for BA, given the lower prevalence of BA and lower utility of HIDA among preterm neonates.Preexisting diagnostic approach to neonatal cholestasis should be modified for preterm cohort, taking into accounts of the prevalence for each etiology, potential predictors and cost-efficiency.

Web-based Calculator for Biliary Atresia Screening in Neonates and Infants with Cholestasis

Accurate Prediction of Biliary Atresia with an Integrated Model Using MMP-7 Levels and Bile Acids.

Development and Assessment of Screening Nomogram for Biliary Atresia Based on Hepatobiliary Ultrasonographic Features.

Development and Validation of Bile Acid Profile-Based Scoring System for Identification of Biliary Atresia: a Prospective Study

[Evaluation of an Automatic Image-Based Screening Technique for Neonatal Hyperbilirubinemia].

Three-color Risk Stratification for Improving the Diagnostic Accuracy for Biliary Atresia

A Novel Prediction Tool Based on Shear Wave Elastography, Gallbladder Ultrasound, and Serum Biomarkers for the Early Diagnosis of Biliary Atresia in Infants Younger Than 60 Days Old

Development and Validation of Novel Diagnostic Models for Biliary Atresia in a Large Cohort of Chinese Patients

Metabonomics Reveals Metabolite Changes in Biliary Atresia Infants

Newborn screening for biliary atresia using direct bilirubin: An implementation science study

Targeted Metabolomics Reveals Birth Screening Biomarkers for Biliary Atresia in Dried Blood Spots

Population-based screening strategies for biliary atresia in the newborn: A systematic review and meta-analysis

Mo1491 – Novel Preoperative Nomograms Predict Microvascular Invasion and Lymph Node Metastasis in Hepatocellular Carcinoma

Cost-Effectiveness Analysis of Universal Screening for Biliary Atresia in Japan

Diagnostic Value and Effectiveness of an Artificial Neural Network in Biliary Atresia

A pathological scoring system in the diagnosis and judgment of prognosis of biliary atresia.

Feasibility of biliary atresia newborn screening in an integrated health network

Biliary atresia and cholestasis plasma non-targeted metabolomics unravels perturbed metabolic pathways and unveils a diagnostic model for biliary atresia

Design and validation of an early scoring system for predicting early outcomes of type III biliary atresia after Kasai’s operation

[Role of a liver pathology standardized scoring system in the diagnosis of congenital biliary atresia and its relationship with prognosis]

Relationship between hepatic function recovery and postoperative cholangitis in neonates undergoing hepaticojejunostomy for biliary atresia